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Abdala, Ana Paula L., Andrea S. Haibara, and Edu-
ardo Colombari. Cardiovascular responses to substance P
in the nucleus tractus solitarii: microinjection study in con-
scious rats. Am J Physiol Heart Circ Physiol 285:
H891–H898, 2003. First published May 8, 2003; 10.1152/
ajpheart.00869.2002.—The cardiovascular effects of sub-
stance P (SP) microinjections in the nucleus tractus solitarii
(NTS) were evaluated in conscious rats. We chose this model
because it is an effective way to access some of the cardio-
vascular effects of neurotransmitters in the NTS without the
inconvenience of blunting pathways with anesthetic agents
or removing forebrain projections by decerebration. The car-
diovascular responses to SP injections were also evaluated
after chronic nodose ganglionectomy. We found that, in con-
scious rats, SP microinjections into the NTS induced hyper-
tension and tachycardia. Unilateral and bilateral SP injec-
tions into the NTS caused a slow increase in blood pressure
and heart rate that peaked 1.5–5 min after injection and
lasted for 20–30 min. Nodose ganglionectomy increased the
duration of the pressor and tachycardic effects of SP and
enhanced the pressor response. These data show that SP in
the NTS is involved in pressor pathways. The supersensitiv-
ity to SP seen after nodose ganglionectomy suggests that
vagal afferent projections are involved in those pressor path-
ways activated by SP in the NTS.
blood pressure; heart rate; neurokinins; brain stem
NUCLEUS TRACTUS SOLITARII (NTS) are the sites of termi-
nation of primary visceral sensory fibers, which convey
information from cardiac vagal receptors, barorecep-
tors, and chemoreceptors (5). These nuclei are densely
innervated by substance P (SP)-like immunoreactive
(SP-LI) nerve terminals, some of which originate from
the vagus and glossopharyngeal nerves (9, 11, 12, 18).
SP-LI is also found in the nodose and petrosal ganglia
(12, 45). SP binding sites are present in the dorsal
vagal complex (DVC), which includes the area pos-
trema, the NTS, and the dorsal motor nucleus of the
vagus (DMNX). The distribution of neurokinin-1
(NK-1) receptors differs throughout different parts of
the DVC. The highest density was detected at interme-
diate levels of both NTS and DMNX (1). Part of the
content of SP in the NTS also derives from trigeminal
afferents and terminal projections from the medullary
raphe nuclei (30, 40, 43).
It has been suggested that SP is a neurotransmitter
or neuromodulator of baroreceptor and chemoreceptor
afferents in the NTS (30). For instance, electrical stim-
ulation of aortic depressor nerves elicited a threefold
increase in SP release in the NTS (26). In addition, SP
postsynaptically potentiated glutamate-induced currents
in DMNX neurons (23). It was suggested that SP might
be released with glutamate as a cotransmitter (30).
In an autoradiographic study, no change in SP bind-
ing was detected in the DVC after unilateral nodose
ganglionectomy or vagotomy (17). This would suggest
that SPmight not be a major neurotransmitter in these
pathways. In contrast, later studies have shown in-
creases in the number of SP binding sites after nodose
ganglionectomy (36) or transection of the carotid sinus
nerve (8).
Previous attempts to elucidate SP function in the
NTS using microinjection techniques in the anesthe-
tized rat have produced contradictory results. Some
studies have reported hypotension and bradycardia
(10, 20), whereas others have shown an increase in
blood pressure and tachycardia (13) or no effect at all
(39). It is possible that some of this variation is due to
the presence of anesthetic agents. For example, the
pressor response elicited by glutamate microinjection
into the NTS of conscious rats is reversed after anes-
thesia (25). It is unknown whether the response to SP
microinjections into the NTS is influenced by anes-
thetic agents.
To clarify the functional effects of SP in the NTS
without the influence of anesthetic agents, in this
study, we used a microinjection technique in nonanes-
thetized rats to determine 1) the cardiovascular effects
elicited by unilateral and bilateral SP microinjections;
and 2) whether chronic unilateral nodose ganglionec-
tomy would lead to increased sensitivity to ipsilateral
SP microinjection into the NTS.
MATERIALS AND METHODS
SP was obtained from Research Biochemical International
(Natick, MA) and dissolved in O2- and CO2-free distilled
Address for reprint requests and other correspondence: E. Colom-
bari, Dept. of Physiology, UNIFESP-EPM, Sa˜o Paulo, SP 04023-062
Brazil (E-mail: colombari@fcr.epm.br).
The costs of publication of this article were defrayed in part by the
payment of page charges. The article must therefore be hereby
marked ‘‘advertisement’’ in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
Am J Physiol Heart Circ Physiol 285: H891–H898, 2003.
First published May 8, 2003; 10.1152/ajpheart.00869.2002.
0363-6135/03 $5.00 Copyright © 2003 the American Physiological Societyhttp://www.ajpheart.org H891
water (0.001, 0.01, 0.1, 0.2, 0.3, 0.5, and 1.0 nmol/100 nl, pH
7.4), shortly before the experiments.
Male Wistar rats (250–300 g body wt) were obtained from
the central animal house of the Universidade Federal de Sa˜o
Paulo-Escola Paulista de Medicina. All protocols were ap-
proved by the Medical Ethics Committee of the Universidade
Federal de Sa˜o Paulo. The rats were housed in individual
cages in a controlled environment and had free access to
commercial rat chow and tap water.
Nodose ganglionectomy. Five days before the experiments,
the animals were anesthetized with 1.5–2% halothane di-
luted in 100% oxygen. The right nodose ganglion was exposed
through a ventral midline cervical incision, retracted cau-
dally to expose the entire ganglion, transected at the rostral
and caudal poles, and removed. The layers of muscle were
sutured. After surgery, the animals received intramuscular
injections of penicillin G (24,000 IU) and streptomycin (10
mg). Sham-operated rats were subjected to the same proce-
dure on the same day, but the ganglion was left intact. The
aim of the nodose removal was to determine the importance
of pathways in the NTS receiving vagal projections to the
pressor responses elicited by SP because it is known that
NTS also receives SP-containing projections from other nu-
clei in the central nervous system.
Brain cannulas and microinjection. Four days before the
experiments, the animals were anesthetized with tribromo-
ethanol (250 mg/kg ip), placed in a stereotaxic apparatus,
and received bilateral guide cannulas in the direction of the
intermediate NTS with the use of the stereotaxic coordinates
used by Paxinos and Watson (33) and a technique used by
Colombari et al. (6). A partial occipital craniotomy was per-
formed to expose the cerebellum, through which two 15-mm-
long stainless steel guide cannulas (23 gauge) were intro-
duced in a perpendicular direction 14.0 mm caudal to the
bregma, 0.5 mm lateral to the midline, and 7.9 below the
skull surface of the bregma. The tip of the guide cannula
aimed 1.0 mm above the NTS. The cannulas were fixed to the
skull with methyl methacrylate polymer and screws and
sealed with a 15-mm-long stainless steel occluder until the
start of the experiment. To inject SP, a 33-gauge needle
connected by polyethylene-10 (PE-10) tubing to a 1-l syringe
(Hamilton; Reno, NV) was used. The needles were 1.0 mm
longer than the guide cannulas. On the day of the experi-
ments, the placement of the cannula was functionally con-
firmed by microinjection of glutamate (L-Glu) (5 nmol/100 nl),
which elicited a pressor response and bradycardia, as re-
ported previously (6, 25).
Arterial cannulas and recording of blood pressure. Twenty-
four hours before experiments, rats were again anesthetized
with (1.5–2%) halothane diluted in (100%) oxygen and in-
strumented with PE-10 arterial cannulas. The cannulas were
filled with heparinized saline (50 U/ml), introduced through a
femoral artery, advanced into the lower abdominal aorta,
sealed with a steel pin, and then tunneled subcutaneously at
an exit point to the nape of the neck.
For experiments, the arterial cannula was connected to a
pressure transducer (model P23 ZL, Statham Gould; Oxnard,
CA). Pressure was recorded on a polygraph (model 7D, Grass
Instruments; Quincy, MA). Mean arterial pressure (MAP)
was determined by feeding the signal into the 7D-driver
amplifier with the half-amplitude frequency adjusted to 0.5
Hz. Heart rate (HR) was monitored by means of a cardiota-
chometer (model 7P44C, Grass Instruments) triggered by the
systolic pressure rise.
The arterial pressure and heart rate of conscious freely
moving rats were monitored before and after bilateral or
unilateral 100-nl microinjections of SP or distilled water
(vehicle). Not more than three doses of SP were microinjected
in the same animal. Unilateral and bilateral microinjections
were performed in different animals. When more than one
dose was tested in the same animal, the doses were random-
ized and microinjections were performed at least 1 h apart.
Histology. After the experiments were completed, the in-
jection site was marked with 100 nl of 2% Evans blue dye.
Animals were then anesthetized and perfused transcardially
with 10% buffered formalin. The brains were removed,
placed in formalin for 48 h, followed by 20% sucrose solution
for an additional 48 h. The brains were frozen in a cryostatic
microtome (Jung Histoslide 2000, Leica Instruments) and
40-m-thick coronal sections of the medulla oblongata were
cut. Sections were mounted on slides and counterstained
with 1% neutral red (24).
Statistics. Results are expressed as means SE (n no. of
animals). Data were analyzed by one- or two-way analysis of
variance, followed by Dunnett’s or Tukey’s posttest with
statistical software (SigmaStat for Windows, version 2.0,
SPSS; Corte Madera, CA). Values of P  0.05 were consid-
ered significant.
RESULTS
SP microinjections into NTS of conscious rats. Uni-
lateral SP microinjections into the NTS of conscious
normotensive rats (basal MAP 116 2 mmHg; basal
Fig. 1. Typical recordings of changes
in pulsatile and mean arterial blood
pressure (AP) and heart rate (HR) af-
ter injection of vehicle and substance P
(SP) (1.0 nmol/100 nl) into the nucleus
tractus solitarii (NTS) of a conscious
rat.
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HR  332  7 beats/min; n  37) increased MAP and
HR, whereas microinjections of vehicle did not cause
visible changes in these parameters (Fig. 1). Figure 2
summarizes the cardiovascular changes 5 min after
the moment of injection, when the changes were max-
imal. Doses 0.1 nmol had no effect (P  0.05). With
higher doses, MAP started to rise after 1–2 min, and
reached a plateau within 5 min (Fig. 1). The pressor
response to 1.0 nmol of SP (Fig. 3B) was still detectable
10 and 20 min after the microinjection (18  3 and
14  3 mmHg, respectively; P  0.05). The duration
of the response decreased proportionally with smaller
doses, 10 min for 0.5 nmol of SP and 5 min for 0.2
nmol (19  5 and 9  5 mmHg, respectively, P 
0.05). The tachycardic response induced by SP micro-
injection began within 1–2 min, reached a plateau
within 5 min, and ended after 10 min for 0.5 and 1.0
nmol of SP (Fig. 3B). No behavioral responses were
observed at any moment after unilateral injections of
SP. Cardiovascular effects elicited by unilateral SP
microinjections at a dose close to the ED50 (0.3 nmol)
was completely blocked by previous injection of the
NK-1 antagonist WIN-51708 (5 nmol/100 nl) at the
same site (18  3 vs. 3  1 mmHg and 33  7 vs.
2  6 beats/min, P  0.05, n  5). Baseline MAP and
HR were not altered by unilateral WIN-51708 micro-
injections.
Bilateral SP microinjections (1 nmol in 100 nl) in
conscious normotensive rats (basal MAP  114  2
mmHg and basal HR  324  14 beats/min; n  12)
induced greater pressor responses that reached the
peak more rapidly (Fig. 3B). MAP increased within 10 s
after microinjections and reached a plateau within 1.5
min (43  4 mmHg, P  0.05). The duration of the
pressor response did not differ from that after unilat-
eral microinjection. HR responses reached a peak 5
min after bilateral SP microinjections and did not
differ from unilateral microinjections. However, the
duration of tachycardic responses was greater for bi-
lateral microinjections (Fig. 3B).
Figure 3A summarizes cardiovascular changes after
unilateral and bilateral microinjections of 0.1 nmol of
SP into the NTS. Although this dose had no detectable
effect in unilateral microinjections, it significantly in-
creased MAP at 1.5 and 5 min when microinjected
bilaterally (29 6 and21 4 mmHg, respectively).
After the bilateral SP injections, the rats usually ini-
tiated exploratory behavior, followed by grooming,
which never lasted 2 min.
Vehicle (distilled water) was injected into the NTS
either before or after SP microinjections. Unilateral
(n  8) and bilateral (n  10) microinjections of
distilled water (100 nl) failed to change MAP and HR
(P  0.1).
Fig. 2. Changes in mean arterial pressure (	MAP) and heart rate
(	HR) 5 min after unilateral SP microinjection into the NTS of
conscious rats. [0.001 nmol SP (n 8), 0.01 nmol SP (n 8), 0.1 nmol
SP (n 9), 0.2 nmol SP (n 8), 0.3 nmol SP (n 5), 0.5 nmol SP (n
9), and 1.0 nmol SP (n  9)]. *P  0.05, different from baseline
(Dunnett).
Fig. 3. 	MAP and 	HR induced by unilateral or bilateral SP micro-
injections into the NTS of conscious rats. A: 0.1 nmol SP (unilateral,
n  9; bilateral, n  9). B: 1.0 nmol SP (unilateral, n  9; bilateral,
n  11). *P  0.05, different from basal value (Dunnett); †P  0.05,
different from the corresponding time for unilateral microinjection
(Tukey).
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Effects of nodose ganglionectomy on SP-induced car-
diovascular changes. Removal of the right nodose gan-
glion potentiated the pressor response to unilateral
microinjection of SP (0.2 and 1.0 nmol) into the ipsilat-
eral NTS (Fig. 4, B and C). Injection of 0.1 nmol of SP
significantly increased blood pressure in rats submit-
ted to ganglionectomy, and not in controls, but the
difference between the groups was not significant
(Fig. 4A).
Removal of the nodose ganglion did not alter the
peak HR response (5 min) induced by 1.0 nmol of SP;
however, tachycardic response was potentiated 10 and
20 min after the microinjection (Fig. 4C).
Control microinjections of distilled water (100 nl)
into the NTS of animals submitted to nodose gan-
glionectomy (n  7) or sham surgery (n  4) failed to
change MAP and HR (P  0.1). Removal of the nodose
ganglion did not change basal MAP and HR (119  4
mmHg and 345  10 beats/min) compared with sham-
operated animals (116  6 mmHg and 341  21 beats/
min).
Histological analysis. All animals included in this
study had injection sites located in the NTS, centered
at the level of the area postrema (Fig. 5, A, C, and D).
In a few additional rats, injection sites were located in
the DMNX, hypoglossal nucleus, adjacent areas out-
side the NTS (Fig. 5B), and the fourth ventricle (not
shown). Injections into these sites did not cause cardio-
vascular changes. The centers of injection sites and
spread of the injectate (100 nl) in animals that under-
went nodose ganglion removal (Fig. 5C) were similar to
those from animals submitted sham surgery (Fig. 5D).
DISCUSSION
The present study describes the cardiovascular ef-
fects elicited by SP microinjections into the NTS of rats
in absence of anesthetic agents. Because chronic deaf-
ferentation of cardiovascular input to the NTS causes
an increase in SP binding sites (8, 36), we also deter-
mined whether this morphological response could be
translated into increased sensitivity to SP microinjec-
tion into the NTS of conscious rats.
The present study shows that in the conscious rat,
microinjections of SP (0.1–1.0 nmol/100 nl), either uni-
laterally or bilaterally, induced increase in blood pres-
sure and HR that could be detected for a relatively long
period of time (at least 20 min). Lower doses of SP
(0.001 and 0.01 nmol/100 nl) had no cardiovascular
effects. The pressor/tachycardic effect of a dose close to
the ED50 was blocked by previous injection of a NK-1
antagonist as reported previously (44). Most studies in
anesthetized animals using low doses of SP (0.00007–
0.06 nmol) have reported short lasting hypotension (4,
Fig. 4. 	MAP and 	HR induced by unilateral SP microinjections into the NTS of conscious rats 5 days after
ipsilateral nodose ganglionectomy or sham surgery. A: 0.1 nmol SP microinjections (n  7 for sham, n  11 for
ganglionectomy). B: 0.2 nmol SP microinjections (n  8 for sham, n  10 for ganglionectomy). C: 1.0 nmol SP
microinjections (n  9 for sham, n  12 for ganglionectomy). *P  0.05, different from basal value (Dunnett); †P 
0.05, different from the corresponding time in sham-operated group (Tukey).
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10, 14, 15, 20, 27), whereas higher doses (0.07–7.0
nmol) induced long lasting pressor responses or had no
effect (13, 27, 39). A recent study (2) in a preparation
free of anesthetic agents reported increase in perfusion
pressure (vasoconstriction) after SP microinjection into
the NTS (0.1–100 pmol/40 nl). Taken together, these
results suggest that SP effects might depend on the
dose microinjected and are also influenced by the pres-
ence of anesthetic agents. A similar pattern of response
is observed for L-Glu microinjections, which induce
hypotension in anesthetized rats and hypertension in
conscious ones (6, 25). It has been suggested that a
coexistence of SP and L-Glu in primary baroreceptor
and chemoreceptor afferents in the NTS (34). There is
evidence that the pressor response to L-Glu in con-
scious rats depends on the integrity of chemoreflex
pathways (7). It is possible that chemoreflex pathways
are blunted in anesthetized animals, and, as a conse-
quence, the effect of L-Glu on baroreflex pathways
prevails.
The difficulty in interpreting data from microinjec-
tion studies in the NTS is due to the considerable
overlap of different modality inputs. Although the NTS
can be subdivided based on the cytoarchitecture and
neurochemistry of certain cell groups, visceral afferent
inputs that terminate in various NTS subnuclei have
loose somatotopic organization (32). Consequently, lo-
cal microinjections may affect multiple pathways si-
multaneously and the presence of anesthetic agents
may affect these circuits differentially.
Even without the influence of anesthetic agents, one
might consider that microinjections having effects on
multiple circuits could produce results that are difficult
to interpret. However, a peculiarity in the arrange-
ment of the biochemical machinery related to tachyki-
nin release and degradation raises the possibility that
even endogenously released SP may activate different
circuits lying in the vicinity. SP is believed to be inac-
tivated in the central nervous system mainly by enzy-
matic degradation. It has been suggested that the
principal enzyme responsible for this action is the
neutral endopeptidase 3.4.24.11 (30). Interestingly,
neutral endopeptidase 3.4.24.11 labeling is largely con-
fined to the border of the NTS where light to moderate
staining was observed in the region ventral to the area
postrema (21). This could explain the long-lasting ef-
fects of higher doses of SP in the NTS because enzy-
matic degradation of the exogenous peptide would oc-
Fig. 5. Schematic drawings of consec-
utive coronal sections from the me-
dulla oblongata showing the interme-
diate region of the NTS. Hatched areas
represent the spread of injectate (100
nl). A: overlap of unilateral injection
sites from five representative rats. B:
misplaced injection sites (n  4). C:
overlap of unilateral injection sites
from five representative rats submit-
ted to removal of the nodose ganglion.
D: overlap of unilateral injection sites
from five representative rats submit-
ted to sham surgery. Numbers at the
right indicate the distance from the
bregma (in mm). AP, area postrema;
sol, tractus solitarius; X, dorsal motor
nucleus of the vagus nerve; XII, hypo-
glossal nucleus.
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cur slowly. Even small doses of SP were shown to have
long-lasting effects (15 min) on baroreceptor reflex sen-
sitivity (2). Whereas enzyme labeling was found to be
more intense in caudal levels of the DVC, NK-1 immu-
noreactivity was moderate at caudal and subpostremal
levels of the NTS compared with rostral levels (1).
Hence, a nonsynaptic volume transmission mechanism
for SP in the DVC has been proposed. This type of
transmission can explain the sustained effects of SP
observed in the present study. Extensive studies on the
cellular and subcellular distribution of SP receptors in
the DVC have shown that they are highly concentrated
in sites free of any contact (synaptic or not) with axon
terminals, supporting the volume transmission hy-
pothesis (1, 22). Considering the data available on the
organization of peptidergic circuits, SP-induced de-
pressor/bradycardic response observed in previous
studies (10, 20) does not prove an action of SP in
baroreceptor reflex pathways, neither does the ob-
served pressor/tachycardic response exclude this pos-
sibility.
Several findings further suggest that SP has a mod-
ulatory role on different pathways in the NTS, espe-
cially when it comes to the integration of functionally
antagonistic reflexes. A microinjection study in anes-
thetized dogs showed that SP in the NTS increased the
baroreflex sensitivity, and the converse was observed
for a SP receptor antagonist (35). In anesthetized rats,
SP microinjection into the intermediate and caudal
levels of NTS enhanced baroreceptor reflex sensitivity;
this effect was abolished by previous depletion of nor-
adrenergic fibers and nerve terminals. It was sug-
gested that this SP-induced enhancement in baroreflex
sensitivity could be mediated by an increase in nor-
adrenaline extracellular concentration (3). Synaptic in-
teractions between SP and Glu, a putative neurotrans-
mitter of baroreceptor afferents (38), have been ob-
served in central terminals from peripheral sensory
receptors (30). In DMNX neurons, SP postsynaptically
potentiated Glu-induced currents (23). In the NTS,
70% of the neurons excited by SP but not by angioten-
sin II (ANG II) were also excited by Glu, suggesting a
coexistence of these two neurotransmitters in primary
baroreceptor and chemoreceptor afferents (34). It is
well known that SP accounts for some of the ANG II
actions in the NTS (31). A microinjection study of the
effects of ANG II on cardiorespiratory reflexes in the
working heart-brain stem preparation, which is free of
anesthetic agents, showed that ANG II potentiated
sodium cyanide-induced bradycardia and this effect
was abolished with the use of the NK-1 receptor an-
tagonist (31). Electrophysiological studies showed that
stimulation of the tractus solitarius elicited larger ex-
citatory postsynaptic potentials in NTS neurons in the
presence of ANG II, and this effect was also sensitive to
NK1 receptor blockade (19). The authors suggested
that the ANG II-induced enhancement of chemoreflex
bradycardia was mediated with SP and that the poten-
tiating actions of SP on nonbaroreceptive NTS neurons
could cause an inhibition of the baroreceptor reflex via
inhibitory interneurons (32). Injections of SP into the
medial NTS also potentiated pressor reflex responses
induced by isometric muscle contractions in cats (41).
There is evidence that the activation of ergoreceptors
induces release of SP in the medial NTS (42). A recent
study (2) in a preparation free of anesthetic agents
showed that nociceptive attenuation of baroreceptor
reflex depends on endogenous release of SP acting on
GABAergic neurons in the NTS. Both studies provide
evidence for a participation of endogenous SP in pres-
sor pathways in the NTS. However, another recent
study in spontaneously hypertensive rats (SHR) sug-
gested the participation of endogenously released SP in
postexercise hypotension (4). Taken together, these
data suggest that the SP-induced pressor/tachycardic
response observed in the present study may be related
to the potentiating action of this peptide on nonbarore-
ceptive pathways (possibly those receiving chemore-
ceptor input), resulting in inhibition of the baroreflex
and overriding possible potentiating effects of SP in
this same pathway.
The present study showed that removal of the right
nodose ganglion potentiated the cardiovascular re-
sponses to injection of SP into the NTS. Deafferenta-
tion of vagal input was achieved by the removal of the
nodose ganglion and thus the cell bodies of origin of
visceral afferents of the vagus nerve. This procedure
aims the reduction in the content and release of neu-
rotransmitters (including SP) in the NTS, as a conse-
quence receptors expression increases. Although other
interventions, such as transection of the vagus caudal
to the ganglion also lead to reduction in the release of
neurotransmitters, they may not reduce significantly
their content (17).
Biosynthesis of tachykinins is likely to be confined to
the perikaryon and axonal transport is the sole source
of SP in the nerve terminals (30). Thus, removing or
killing cells of the nodose ganglion, or transection of
their rostral axons, can reduce SP content in the NTS
(12, 16, 27). Neuroanatomic studies have shown super-
sensitivity of SP receptors in the NTS either after
nodose ganglionectomy or transection of the carotid
sinus nerve. There is no evidence of any changes in SP
content or binding sites in the NTS contralateral to the
deafferentation (8, 36).
Supersensitivity may not be the only phenomenon
associated with the increased tachycardic response af-
ter nodose ganglionectomy observed in this study. This
procedure also removes efferent vagal fibers that orig-
inate in the nucleus ambiguus. Vagotomy reduces SP
binding sites in nucleus ambiguus, suggesting that SP
receptors located in this nucleus could be diminished
by chromatolytic changes that occur after peripheral
axotomy (17). If SP is simultaneously potentiating
baroreflex and nonbaroreflex-related pathways and the
latest inhibits the former overriding its effects as sug-
gested above, then a reduction in vagal output could be
responsible for the enhancement in the SP-induced
tachycardic effect observed in this study. However, this
does not exclude an effect on circuitry mediating car-
diovascular and respiratory reflexes.
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In summary, the present study shows that SP micro-
injections into the NTS of conscious rats increases
blood pressure and heart rate. This opposes the effects
observed in previous studies with anesthetized rats,
considering similar doses and volumes injected. The
tachycardic effect suggests an inhibition of baroreflex
related pathways, probably via a potentiating action in
nonbaroreflex pathways. In anesthetized animals,
those pathways could be blunted, resulting in different
responses to SP microinjection. We also observed su-
persensitivity to SP microinjection into the NTS of
conscious rats 5 days after vagal deafferentation. This
data further supports the hypothesis that SP has an
active modulatory function in baseline conditions in
normotensive animals.
Provided that neuropeptides are usually associated
with long-term modulation of different integrative re-
gions of the central nervous system that receive pe-
ripheral sensory input, dysfunctions in these modula-
tory systems may be associated with some chronic
neurogenic diseases. For example, SHR have increased
number of SP binding sites in some regions of the
central nervous system, including the DVC (37). SP-
like immunoreactivity is increased in the caudal NTS
of SHR (28, 29). Other than this, there is little infor-
mation concerning a possible contribution of SP to the
pathogenesis of hypertension. Therefore, further stud-
ies in nonanesthetized animals will be necessary for a
better understanding of the role of SP as a modulator of
cardiovascular reflexes and as a possible contributing
factor for chronic cardiovascular diseases.
We thank Dr. Gus Schoorlemmer for comments on the draft
version of this manuscript.
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